These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33567919)

  • 1. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from
    Sheervalilou R; Shirvaliloo M; Sargazi S; Ghaznavi H
    Expert Opin Drug Deliv; 2021 Jul; 18(7):949-977. PubMed ID: 33567919
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.
    Israel LL; Galstyan A; Holler E; Ljubimova JY
    J Control Release; 2020 Apr; 320():45-62. PubMed ID: 31923537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021).
    Mao Z; Li X; Wang P; Yan H
    Expert Opin Ther Pat; 2022 Sep; 32(9):939-952. PubMed ID: 35929879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery.
    Stanicki D; Vangijzegem T; Ternad I; Laurent S
    Expert Opin Drug Deliv; 2022 Mar; 19(3):321-335. PubMed ID: 35202551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications.
    Cotin G; Blanco-Andujar C; Perton F; Asín L; de la Fuente JM; Reichardt W; Schaffner D; Ngyen DV; Mertz D; Kiefer C; Meyer F; Spassov S; Ersen O; Chatzidakis M; Botton GA; Hénoumont C; Laurent S; Greneche JM; Teran FJ; Ortega D; Felder-Flesch D; Begin-Colin S
    Nanoscale; 2021 Sep; 13(34):14552-14571. PubMed ID: 34473175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.
    Liu H; Zhang J; Chen X; Du XS; Zhang JL; Liu G; Zhang WG
    Nanoscale; 2016 Apr; 8(15):7808-26. PubMed ID: 27029509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron oxide nanoparticle targeting mechanism and its application in tumor magnetic resonance imaging and therapy.
    Wu L; Wang C; Li Y
    Nanomedicine (Lond); 2022 Sep; 17(21):1567-1583. PubMed ID: 36458585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Magnetic Nanoplatforms for Cancer Theranostics.
    Jiao W; Zhang T; Peng M; Yi J; He Y; Fan H
    Biosensors (Basel); 2022 Jan; 12(1):. PubMed ID: 35049666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare-Earth Doped Iron Oxide Nanostructures for Cancer Theranostics: Magnetic Hyperthermia and Magnetic Resonance Imaging.
    Laha SS; Thorat ND; Singh G; Sathish CI; Yi J; Dixit A; Vinu A
    Small; 2022 Mar; 18(11):e2104855. PubMed ID: 34874618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications.
    Frtús A; Smolková B; Uzhytchak M; Lunova M; Jirsa M; Kubinová Š; Dejneka A; Lunov O
    J Control Release; 2020 Dec; 328():59-77. PubMed ID: 32860925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.
    Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V
    Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future Advances in Diagnosis and Drug Delivery in Interventional Radiology Using MR Imaging-Steered Theranostic Iron Oxide Nanoparticles.
    Dimov IP; Tous C; Li N; Häfeli UO; Martel S; Soulez G
    J Vasc Interv Radiol; 2021 Sep; 32(9):1292-1295.e1. PubMed ID: 34462079
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
    Ling D; Lee N; Hyeon T
    Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size-Controlled Iron Oxide Nanoplatforms with Lipidoid-Stabilized Shells for Efficient Magnetic Resonance Imaging-Trackable Lymph Node Targeting and High-Capacity Biomolecule Display.
    Clauson RM; Chen M; Scheetz LM; Berg B; Chertok B
    ACS Appl Mater Interfaces; 2018 Jun; 10(24):20281-20295. PubMed ID: 29883088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.
    Xie W; Guo Z; Gao F; Gao Q; Wang D; Liaw BS; Cai Q; Sun X; Wang X; Zhao L
    Theranostics; 2018; 8(12):3284-3307. PubMed ID: 29930730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Surface Chemistry in Mediating the Uptake of Ultrasmall Iron Oxide Nanoparticles by Cancer Cells.
    Narkhede AA; Sherwood JA; Antone A; Coogan KR; Bolding MS; Deb S; Bao Y; Rao SS
    ACS Appl Mater Interfaces; 2019 May; 11(19):17157-17166. PubMed ID: 31017392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic iron oxide nanogels for combined hyperthermia and drug delivery for cancer treatment.
    Patri S; Thanh NTK; Kamaly N
    Nanoscale; 2024 Aug; 16(33):15446-15464. PubMed ID: 39113663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.